Latest filing published 25 Jan 2022 for Merrimack Pharmaceuticals INC, €53k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ulrik B. Nielsen: trading record in brief
Ulrik B. Nielsen is a declared insider of Merrimack Pharmaceuticals Inc (board member), with filings sourced from SEC (Form 4). Between 16 July 2012 and 24 January 2022, the trades on record add up to 37 filings.
The open-market side counts 1 purchase for €53k alongside 14 sales for €3.9M. Netting one side against the other leaves €3.8M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 22 option exercises. Since January 2022: 1 purchase and no sales on the market.
The newest entry dates from 25 January 2022: an open-market purchase of €53k, in Merrimack Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ulrik B. Nielsen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,287 shares@ US$4.2437100.0% of flowCommon StockSEC:0000899243-22-003143:0Canonical exit: 24 Apr 2022 (T+90)
- 100 shares@ US$13.200.2% of flowCommon StockSEC:0001209191-17-053004:0
- 100 shares@ US$14.200.2% of flowCommon StockSEC:0001209191-17-053004:1
- 7,133 shares@ US$13.2010.8% of flowCommon StockSEC:0001209191-17-053004:2
- 663 shares@ US$13.201.0% of flowCommon StockSEC:0001209191-17-053004:3
- 7,796 shares@ US$14.2312.7% of flowCommon StockSEC:0001209191-17-053004:4
- 14,756 shares@ US$13.2022.2% of flowCommon StockSEC:0001209191-17-052684:0
- 14,756 shares@ US$14.4624.3% of flowCommon StockSEC:0001209191-17-052684:1
- 6,800 shares@ US$13.2010.3% of flowCommon StockSEC:0001209191-17-052684:2
- 6,800 shares@ US$14.2711.1% of flowCommon StockSEC:0001209191-17-052684:3
- 20,000 shares@ US$2.59Common StockSEC:0001179110-15-011404:0
- 20,000 shares@ US$10.71Common StockSEC:0001179110-15-011404:1
- 10,000 shares@ US$2.47Common StockSEC:0001179110-15-010110:0
- 30,000 shares@ US$2.59Common StockSEC:0001179110-15-010110:1
- 40,000 shares@ US$12.02Common StockSEC:0001179110-15-010110:2
- 23,175 shares@ US$2.47Common StockSEC:0001179110-15-008112:0
- 16,825 shares@ US$2.47Common StockSEC:0001179110-15-008112:1
- 40,000 shares@ US$13.04Common StockSEC:0001179110-15-008112:2
- 25,000 shares@ US$2.47Common StockSEC:0001179110-15-007941:0
- 15,000 shares@ US$1.71Common StockSEC:0001179110-15-006470:0
- 25,000 shares@ US$1.81Common StockSEC:0001179110-15-006470:1
- 40,000 shares@ US$12.88Common StockSEC:0001179110-15-006470:2
- 40,000 shares@ US$1.71Common StockSEC:0001179110-15-005302:0
- 40,000 shares@ US$11.97Common StockSEC:0001179110-15-005302:1
- 20,000 shares@ US$1.71Common StockSEC:0001179110-15-004408:0
25 of 37 declarations
